Biosynex SA (EPA:ALBIO)

Biosynex Statistics

Total Valuation

Biosynex has a market cap or net worth of EUR 20.62 million. The enterprise value is 73.81 million.

Market Cap	20.62M
Enterprise Value	73.81M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Biosynex has 18.75 million shares outstanding. The number of shares has increased by 32.73% in one year.

Current Share Class	18.75M
Shares Outstanding	18.75M
Shares Change (YoY)	+32.73%
Shares Change (QoQ)	+74.10%
Owned by Insiders (%)	5.70%
Owned by Institutions (%)	n/a
Float	8.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.18
PB Ratio	0.59
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.57, with an EV/FCF ratio of -8.61.

EV / Earnings	-1.27
EV / Sales	0.64
EV / EBITDA	13.57
EV / EBIT	n/a
EV / FCF	-8.61

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 1.76.

Current Ratio	3.24
Quick Ratio	1.91
Debt / Equity	1.76
Debt / EBITDA	10.99
Debt / FCF	-7.19
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -100.73% and return on invested capital (ROIC) is -42.48%.

Return on Equity (ROE)	-100.73%
Return on Assets (ROA)	-17.88%
Return on Invested Capital (ROIC)	-42.48%
Return on Capital Employed (ROCE)	-39.74%
Weighted Average Cost of Capital (WACC)	2.13%
Revenue Per Employee	253,590
Profits Per Employee	-128,247
Employee Count	454
Asset Turnover	0.70
Inventory Turnover	1.54

Taxes

Income Tax	-1.10M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.01% in the last 52 weeks. The beta is 0.77, so Biosynex's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	+24.01%
50-Day Moving Average	0.86
200-Day Moving Average	0.85
Relative Strength Index (RSI)	86.56
Average Volume (20 Days)	68,686

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biosynex had revenue of EUR 115.13 million and -58.22 million in losses.

Revenue	115.13M
Gross Profit	72.29M
Operating Income	-47.33M
Pretax Income	-59.24M
Net Income	-58.22M
EBITDA	5.61M
EBIT	-47.33M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 8.46 million in cash and 61.65 million in debt, with a net cash position of -53.19 million or -2.84 per share.

Cash & Cash Equivalents	8.46M
Total Debt	61.65M
Net Cash	-53.19M
Net Cash Per Share	-2.84
Equity (Book Value)	34.95M
Book Value Per Share	n/a
Working Capital	38.42M

Cash Flow

In the last 12 months, operating cash flow was -5.89 million and capital expenditures -2.69 million, giving a free cash flow of -8.57 million.

Operating Cash Flow	-5.89M
Capital Expenditures	-2.69M
Depreciation & Amortization	24.69M
Net Borrowing	-2.60M
Free Cash Flow	-8.57M
FCF Per Share	-0.46

Margins

Gross margin is 62.79%, with operating and profit margins of -41.11% and -50.57%.

Gross Margin	62.79%
Operating Margin	-41.11%
Pretax Margin	-51.45%
Profit Margin	-50.57%
EBITDA Margin	4.87%
EBIT Margin	-41.11%
FCF Margin	n/a

Dividends & Yields

Biosynex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.73%
Shareholder Yield	-32.73%
Earnings Yield	-282.33%
FCF Yield	-41.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5